Advertisement

RE.: Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancer

  • Sixten HarborgEmail author
  • Deirdre P. Cronin-Fenton
  • Signe Borgquist
Letter to the Editor
  • 34 Downloads

Notes

Compliance with ethical standards

Conflict of interest

There are no conflicts of interest.

Ethical approval

Not applicable.

Informed consent

Not applicable.

References

  1. 1.
    Suissa S (2008) Immortal time bias in pharmacoepidemiology. Am J Epidemiol 167(4):492–499CrossRefGoogle Scholar
  2. 2.
    Hernán MA (2018) How to estimate the effect of treatment duration on survival outcomes using observational data. BMJ 360:k182CrossRefGoogle Scholar
  3. 3.
    Harrell F (2015) Regression modeling strategies, 2nd edn. Springer International Publishing, Switzerland, p 582CrossRefGoogle Scholar
  4. 4.
    Ahern TP et al (2014) Statins and breast cancer prognosis: evidence and opportunities. Lancet Oncol 15(10):e461–e468CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Aarhus University HospitalAarhusDenmark
  2. 2.Aarhus UniversityAarhusDenmark
  3. 3.Lund UniversityLundSweden

Personalised recommendations